These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 26811657)

  • 21. Evaluating the clinical feasibility: The direct bisulfite genomic sequencing for examination of methylated status of protocadherin10 (PCDH10) promoter to predict the prognosis of gastric cancer.
    Hou YC; Deng JY; Zhang RP; Xie XM; Cui JL; Wu WP; Hao XS; Liang H
    Cancer Biomark; 2015; 15(5):567-73. PubMed ID: 26406945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Causes and consequences of microsatellite instability in gastric carcinogenesis.
    Velho S; Fernandes MS; Leite M; Figueiredo C; Seruca R
    World J Gastroenterol; 2014 Nov; 20(44):16433-42. PubMed ID: 25469011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epstein-barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma.
    Kang GH; Lee S; Kim WH; Lee HW; Kim JC; Rhyu MG; Ro JY
    Am J Pathol; 2002 Mar; 160(3):787-94. PubMed ID: 11891177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epstein-Barr virus-positive gastric cancer: a distinct molecular subtype of the disease?
    Jácome AA; Lima EM; Kazzi AI; Chaves GF; Mendonça DC; Maciel MM; Santos JS
    Rev Soc Bras Med Trop; 2016 Apr; 49(2):150-7. PubMed ID: 27192582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific expression and methylation of SLIT1, SLIT2, SLIT3, and miR-218 in gastric cancer subtypes.
    Kim M; Kim JH; Baek SJ; Kim SY; Kim YS
    Int J Oncol; 2016 Jun; 48(6):2497-507. PubMed ID: 27082735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An updated review of gastric cancer in the next-generation sequencing era: insights from bench to bedside and vice versa.
    Yamamoto H; Watanabe Y; Maehata T; Morita R; Yoshida Y; Oikawa R; Ishigooka S; Ozawa S; Matsuo Y; Hosoya K; Yamashita M; Taniguchi H; Nosho K; Suzuki H; Yasuda H; Shinomura Y; Itoh F
    World J Gastroenterol; 2014 Apr; 20(14):3927-37. PubMed ID: 24744582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cooperative participation of epigenomic and genomic alterations in the clinicopathological diversity of gastric adenocarcinomas: significance of cell adhesion and epithelial-mesenchymal transition-related signaling pathways.
    Yang M; Arai E; Takahashi Y; Totsuka H; Chiku S; Taniguchi H; Katai H; Sakamoto H; Yoshida T; Kanai Y
    Carcinogenesis; 2020 Nov; 41(11):1473-1484. PubMed ID: 32710740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular classification of gastric cancer.
    Chia NY; Tan P
    Ann Oncol; 2016 May; 27(5):763-9. PubMed ID: 26861606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathologic and molecular characteristics of synchronous colorectal cancers: heterogeneity of clinical outcome depending on microsatellite instability status of individual tumors.
    Bae JM; Cho NY; Kim TY; Kang GH
    Dis Colon Rectum; 2012 Feb; 55(2):181-90. PubMed ID: 22228162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetics/genomics/proteomics of gastric adenocarcinoma.
    Uppal DS; Powell SM
    Gastroenterol Clin North Am; 2013 Jun; 42(2):241-60. PubMed ID: 23639639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genome-wide identification of Epstein-Barr virus-driven promoter methylation profiles of human genes in gastric cancer cells.
    Zhao J; Liang Q; Cheung KF; Kang W; Lung RW; Tong JH; To KF; Sung JJ; Yu J
    Cancer; 2013 Jan; 119(2):304-12. PubMed ID: 22833454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma.
    An C; Choi IS; Yao JC; Worah S; Xie K; Mansfield PF; Ajani JA; Rashid A; Hamilton SR; Wu TT
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):656-63. PubMed ID: 15701853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus.
    Chang MS; Uozaki H; Chong JM; Ushiku T; Sakuma K; Ishikawa S; Hino R; Barua RR; Iwasaki Y; Arai K; Fujii H; Nagai H; Fukayama M
    Clin Cancer Res; 2006 May; 12(10):2995-3002. PubMed ID: 16707594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive molecular characterization of gastric adenocarcinoma.
    Cancer Genome Atlas Research Network
    Nature; 2014 Sep; 513(7517):202-9. PubMed ID: 25079317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chromosomal Instability in Gastric Cancer: Role in Tumor Development, Progression, and Therapy.
    Nemtsova MV; Kuznetsova EB; Bure IV
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Molecular Subtypes of Gastric Cancer].
    Hatogai K; Doi T
    Gan To Kagaku Ryoho; 2016 Mar; 43(3):281-5. PubMed ID: 27067842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastric cancer and concomitant renal cancer: a systematic immunohistochemical and molecular analysis.
    Betge J; Pollheimer MJ; Schlemmer A; Hoefler G; Langner C
    Oncol Rep; 2011 Sep; 26(3):567-75. PubMed ID: 21687951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer type-specific epigenetic changes: gastric cancer.
    Calcagno DQ; de Arruda Cardoso Smith M; Burbano RR
    Methods Mol Biol; 2015; 1238():79-101. PubMed ID: 25421656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular pathology of gastric carcinoma.
    Jang BG; Kim WH
    Pathobiology; 2011; 78(6):302-10. PubMed ID: 22104201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging molecular classifications and therapeutic implications for gastric cancer.
    Chen T; Xu XY; Zhou PH
    Chin J Cancer; 2016 May; 35():49. PubMed ID: 27233623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.